Abstract
In familial cases of combined pituitary hormone deficiency the most common mutations are that of Prophet of Pit 1 (PROP1) gene. PROP1 mutations are associated with deficiencies of growth hormone, thyrotropin, prolactin, and gonadotropins (follicle-stimulating hormone and luteinizing hormone), with evolving adrenocorticotropin (ACTH) deficiency in some cases. On imaging in most patients the pituitary gland is hypoplastic, but occasionally transient pituitary enlargement is found. We report a 22-year-old female initially diagnosed at age 12 with familial hypopituitarism due to PROP1 mutation, who presented with coma and respiratory arrest (acute hyponatremia). She was urgently treated in Intensive Care Unit of Emergency Center with hypertonic saline and stress doses of hydrocortisone, which resulted in the fast increase of plasma osmolality resulting in the osmotic demyelination syndrome. Simultaneously and incidentally on computed tomography scan a large sellar and suprasellar mass were reported as possible Rathke’s cleft cyst or craniopharyngioma. Once the patient was stable, ACTH deficiency was documented. She remained replaced with hydrocortisone and subsequently underwent transphenoidal surgery. The removed sellar content revealed no pituitary adenoma or pituitary cells, but only an eosinophilic, colloid-like mass, and necrotic acellular debris. Her sister with hypopituitarism had an empty sella. Genetic testing in both sisters revealed the same homozygous c.150delA mutation in PROP1 gene. Here we report two sisters with the same PROP1 mutation who presented in adulthood with different pituitary morphology, one of them with a large sellar and suprasellar mass, in which transphenoidal surgery provided an extremely rare opportunity for a histopathological analysis of the sellar content. Due to the lack of endocrine care during the transition period hypocortisolism which evolved, a consequence of PROP1 mutation, was not recognized. Empirical use of hydrocortisone in the Intensive Care in our patient with life-threatening acute hyponatremia was appropriate but because glucocorticoid therapy on its own corrects hyponatremia even after stopping hypertonic saline infusion, the risk for over-correction of hyponatremia in ACTH deficiency is high.
Similar content being viewed by others
References
J.S. Dasen, J.P. Barbera, T.S. Herman, S.O. Connell, L. Olson, B. Ju, J. Tollkuhn, S.H. Baek, D.W. Rose, M.G. Rosenfeld, Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis. Genes Dev. 15, 3193–3207 (2001)
M.W. Sornson, W. Wu, J.S. Dasen, S.E. Flynn, D.J. Norman, S.M. O’Connell, I. Gukovsky, C. Carrière, A.K. Ryan, A.P. Miller, L. Zuo, A.S. Gleiberman, B. Andersen, W.G. Beamer, M.G. Rosenfeld, Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384, 327–333 (1996)
P.J. Gage, M.L. Brinkmeier, L.M. Scarlett, L.T. Knapp, S.A. Camper, K.A.L. Mahon, The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation. Mol. Endocrinol. 10, 1570–1581 (1996)
L.E. Cohen, Genetic regulation of the embryology of the pituitary gland and somatotrophs. Endocrine 12, 99–106 (2000)
M.T. Dattani, I.C. Robinson, The molecular basis for developmental disorders of the pituitary gland in man. Clin. Genet. 57, 337–346 (2000)
S. Mody, M. Brown, J.S. Parks, The spectrum of hypopituitarism caused by PROP1 mutations. Best Pract. Res. Clin. Endocrinol. Metab. 16, 421–431 (2002)
M.T. Dattani, Growth hormone deficiency and combined pituitary hormone deficiency: does the genotype matter? Clin. Endocrinol. 63, 121–130 (2005)
W. Wu, J.P. Cogan, R.W. Pfaffle, J.S. Dasen, H. Frisch, S.M. O′Connell, S.E. Flynn, M.R. Brown, P.E. Mullis, J.S. Parks, J.A. Phillips 3rd, M.G. Rosenfeld, Mutation in PROP1 cause familial combined pituitary hormone deficiency. Nat. Genet. 18, 147–149 (1998)
A.L. Rosenbloom, A.S. Almonte, M.R. Brown, D.A. Fisher, L. Baumbach, J.S. Parks, Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J. Clin. Endocrinol. Metab. 84, 50–57 (1999)
A. Arroyo, F. Pernasetti, V.V. Vasilyev, P. Amato, S.S.C. Yen, P.L. Mellon, A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty. Clin. Endocrinol. 57, 283–291 (2002)
M. Doknic, S. Pekic, M. Djurovic, V. Zivkovic, V. Popovic, Multiple pituitary hormone deficiency (MPHD) associated with normal height, absent puberty and obesity. Pediatr. Endocrinol. Rev. 1, 32–33 (2004)
M.T. Dattani, GH deficiency might be associated with normal height in PROP1 deficiency. Clin. Endocrinol. 57, 157–158 (2002)
T.C. Vieira, M.R. da Silva, J. Abucham, The natural history of the R120C PROP1 mutation reveals a wide phenotypic variability in two untreated adult brothers with combined pituitary hormone deficiency. Endocrine 30, 365–369 (2006)
R. Reynaud, M. Gueydan, A. Saveanu, S. Vallette-Kasic, A. Enjalbert, T. Brue, A. Barlier, Genetic screening of combined pituitary hormone deficiency: experience in 195 patients. J. Clin. Endocrinol. Metab. 91, 3329–3336 (2006)
R. Reynaud, M. Chadli-Chaieb, S. Vallette-Kasic, A. Barlier, J. Sarles, I. Pellegrini-Bouiller, A. Enjalbert, L. Chaieb, T. Brue, A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies. J. Clin. Endocrinol. Metab. 89, 5779–5786 (2004)
J.S. Parks, M.R. Brown, D.L. Hurley, C.J. Phelps, M.P. Wajnrajch, Heritable disorders of pituitary development. J. Clin. Endocrinol. Metab. 84, 4362–4370 (1999)
J. Deladoey, C. Fluck, A. Buyukgebiz, B.V. Kuhlmann, A. Eble, P.C. Hidnmarsh, W. Wu, P.E. Mullis, “Hot spot” in the PROP1 gene responsible for combined pituitary hormone deficiency. J. Clin. Endocrinol. Metab. 84, 1645–1650 (1999)
S. Vallette-Kasic, A. Barlier, C. Teinturier, A. Diaz, M. Manavela, F. Berthezene, P. Bouchard, J.L. Chaussain, R. Brauner, I. Pellegrini-Bouiloler, P. Jaquet, A. Enjalbert, T. Brue, PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J. Clin. Endocrinol. Metab. 86, 4529–4535 (2001)
R. Reynaud, A. Barlier, S. Vallette-Kasic, A. Saveanu, M.P. Guillet, G. Simonin, A. Enjalbert, P. Valensi, T. Brue, An uncommon phenotype with familial central hypogonadism caused by a novel PROP1 gene mutant truncated in the transactivation domain. J. Clin. Endocrinol. Metab. 90, 4880–4887 (2005)
B.B. Mendonca, M.G.F. Osorio, A.C. Latronico, V. Estefan, L. Su Sih Lo, I. Arnhold, Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301,G302 in the PROP1 gene. J. Clin. Endocrinol. Metab. 84, 942–945 (1999)
G. Agarwal, V. Bhatia, S. Cook, P.Q. Thomas, Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion. J. Clin. Endocrinol. Metab. 85, 4556–4561 (2000)
F. Pernasetti, S.P.A. Toledo, V.V. Vasilyev, C.Y. Hayashida, J.D. Cogan, C. Ferrari, D.M. Lourenco, P.L. Mellon, Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the Prophet of Pit-1 gene. J. Clin. Endocrinol. Metab. 85, 390–397 (2000)
A. Bottner, E. Keller, J. Kratzsch, H. Stobbe, J.F.W. Weigel, A. Keller, W. Hirsch, W. Kiess, W.F. Blum, R.W. Pfaffle, PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. J. Clin. Endocrinol. Metab. 89, 5256–5265 (2004)
S. Nakamura, A. Ohtsuru, N. Takamura, G. Kitange, Y. Toukunaga, A. Yasunaga, S. Shibata, S. Yamashita, Prop-1 gene expression in human pituitary tumors. J. Clin. Endocrinol. Metab. 84, 2581–2584 (1999)
K. Thapar, K. Kovacs, B.W. Scheitauer, M.O. Lloyd (eds.), Diagnosis and management of pituitary tumors (Humana press, Totowa, 2001)
R. Carpinteri, I. Patelli, F.F. Casanueva, A. Giustina, Pituitary tumours: inflammatory and granulomatous expansive lesions of the pituitary. Best Pract. Res. Clin. Endocrinol. Metab. 23, 639–650 (2009)
P. Fofanova, N. Takamura, E. Kinoshita, A. Vorontson, V. Vladimirova, I. Dedov, V. Peterkova, S. Yamashita, MR imaging of the pituitary gland in children and young adults with congenital combined pituitary hormone deficiency associated with PROP1 mutations. Am. J. Roentgenol. 174, 555–559 (2000)
A. Voutetakis, M. Argyropoulou, A. Sertedaki, S. Livadas, P. Xekouki, M. Maniati-Christidi, I. Bossis, N. Thalassinos, N. Patronas, C. Dacou-Voutetakis, Pituitary magnetic resonance imaging in 15 patients with Prop1 gene mutations: pituitary enlargement may originate from the intermediate lobe. J. Clin. Endocrinol. Metab. 89, 2200–2206 (2004)
M.G. Abrao, M.V. Leite, L.R. Carvalho, A.E.C. Billerbeck, M.Y. Nishi, A.S. Barbosa, R.M. Martin, I.J.P. Arnhold, B.B. Mendonca, Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion. Clin. Endocrinol. 65, 294–300 (2006)
J.S. Parks, A. Tenore, A.M. Bongiovanni, R.T. Kirkland, Familial hypopituitarism with large sella turcica. N. Engl. J. Med. 298, 698–702 (1978)
F.G. Riepe, C.J. Partsch, O. Blankenstein, H. Monig, R.W. Pfaffle, W.G. Sippell, Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation. J. Clin. Endocrinol. Metab. 86, 4353–4357 (2001)
C. Teinturier, S. Vallete, C. Adamsbaum, M. Bendaoud, T. Brue, P.F. Bougneres, Pseudotumor of the pituitary due to PROP-1 deletion. J. Clin. Endocrinol. Metab. 15, 95–101 (2002)
A. Zygmunt-Gorska, J. Starzyk, D. Adamek, E. Radwanska, P. Sucharski, I. Herman-Sucharska, J.J. Pietrzyk, Pituitary enlargement in patient with PROP1 gene inactivating mutation represents cystic hyperplasia of the intermediate pituitary lobe. Histopathology and over 10 years follow-up of two patients. J. Pediatr. Endocrinol. Metab. 22, 653–660 (2009)
R.D. Ward, L.T. Raetzman, H. Suh, B.M. Stone, I.O. Nasonkin, S.A. Camper, Role of PROP1 in pituitary gland growth. Endocrinol. 19, 698–710 (2005)
J.A. Loh, J.G. Verbalis, Disorders of water and salt metabolism associated with pituitary disease. Endocrinol. Metab. Clin. North Am. 37, 213–234 (2008)
J.G. Verbalis, S.R. Goldsmith, A. Greenberg, R.W. Schrier, R.H. Sterns, Hyponatremia treatment guidelines 2007: expert panel recommendations. Am. J. Med. 120(suppl 1), S1–S21 (2007)
W.B. Schwartz, W. Bennett, S. Curelop, F.C. Bartter, A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am. J. Med. 23, 529–542 (1957)
I.N. Mandell, R.A. DeFronzo, G.L. Robertson, F.N.J. Forrest, Role of plasma arginine vasopressin in the impaired water diuresis of isolated glucocorticoid deficiency in the rat. Kidney Int. 17, 186–195 (1950)
W. Oelkers, Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N. Engl. J. Med. 321, 492–496 (1989)
R.H. Sterns, J.E. Riggs, S.S. Schochet Jr., Osmotic demyelination syndrome following correction of hyponatremia. N. Engl. J. Med. 314, 1535–1542 (1986)
J.G. Verbalis, Hyponatremia. Endocrinologic causes and consequences of therapy. Trends Endocrinol. Metab. 3, 1–7 (1992)
A. Perianayagam, R.H. Sterns, S.M. Silver, M. Grieff, R. Mayo, J. Hix, R. Kouides, DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin. J. Am. Soc. Nephrol. 3, 331–336 (2008)
Acknowledgments
The authors thank Professor Dr. Joseph G. Verbalis, Georgetown University Medical Center, Washington, DC for his substantial and important contribution in discussing the clinical course and management of hyponatremia in our patient. Genetic analysis of the PROP1 gene in both sisters and mother was performed in the Laboratoire de Biologie Moleculaire, Hopital de la Conception, Marseille, France (Prof. Alain Enjalbert). This investigation was supported by a grant from the Ministry of Science of Republic of Serbia (Project 175033) and a grant from the French National Research Agency (ANR-08-GENO-026-01).
Conflict of interest
The authors have nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pekic, S., Doknic, M., Miljic, D. et al. Case seminar: a young female with acute hyponatremia and a sellar mass. Endocrine 40, 325–331 (2011). https://doi.org/10.1007/s12020-011-9516-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-011-9516-8